Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

2.7K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.7K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

871
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
871
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
What are Lipids?01:38

What are Lipids?

225.6K
Overview
225.6K
What are Lipids?01:31

What are Lipids?

12.5K
Lipids function as structural components of cellular membranes, in addition to acting as energy reservoirs and signaling molecules. They are thus crucial to all living organisms.  The three biologically important classes of lipids are triglycerides, phospholipids, and steroids.
Non-Polar and Hydrophobic Characteristics of Lipids
Lipids are a structurally and functionally diverse group of hydrocarbons—compounds consisting of carbon and hydrogen atoms. The carbon-carbon and...
12.5K
What are Lipids?01:31

What are Lipids?

26.4K
26.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-density lipoprotein cholesterol management and goal attainment at 1 year in patients with diabetes, pre-diabetes and normoglycaemia: results from the European, prospective, observational SANTORINI study.

BMJ open·2026
Same author

Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI study.

American journal of preventive cardiology·2026
Same author

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.

Current atherosclerosis reports·2026
Same author

Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

European heart journal·2026
Same author

CETP Inhibitors: Back With a New Target.

Circulation research·2026
Same author

Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular risk.

Journal of the American College of Cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
Same journal

Artificial intelligence for right ventricular assessment: current evidence and future directions.

Current opinion in cardiology·2026
Same journal

Coronary physiology and intravascular imaging in surgical and percutaneous revascularization.

Current opinion in cardiology·2026
Same journal

Cardioneuroablation for children with syncope.

Current opinion in cardiology·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.9K

New worldwide lipid guidelines.

Smriti Saraf1, Kausik K Ray

  • 1aSouth London Healthcare NHS Trust bDepartment of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.

Current Opinion in Cardiology
|June 8, 2015
PubMed
Summary
This summary is machine-generated.

Worldwide lipid guidelines for atherosclerotic cardiovascular disease (ASCVD) vary significantly. Differences in risk scoring and treatment targets create practice variations and impact healthcare costs globally.

More Related Videos

Determination of Total Lipid and Lipid Classes in Marine Samples
14:59

Determination of Total Lipid and Lipid Classes in Marine Samples

Published on: December 11, 2021

5.5K
Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

10.4K

Related Experiment Videos

Last Updated: Apr 11, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.9K
Determination of Total Lipid and Lipid Classes in Marine Samples
14:59

Determination of Total Lipid and Lipid Classes in Marine Samples

Published on: December 11, 2021

5.5K
Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

10.4K

Area of Science:

  • Cardiology
  • Public Health
  • Evidence-Based Medicine

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) is a major global health burden.
  • Modifying lipid risk factors is crucial for reducing ASCVD incidence and improving outcomes.

Purpose of the Study:

  • To compare recent international lipid guidelines for ASCVD management.
  • To highlight variations in clinical practice across different regions.

Main Methods:

  • Review and comparison of updated lipid management guidelines from the UK (NICE), USA (ACC/AHA), Canada, and Europe (ESC/EAS).
  • Analysis of guideline approaches: risk-based versus target-based strategies.
  • Examination of differing risk scoring systems employed by various guidelines.

Main Results:

  • UK and US guidelines (2013-2014) are risk-based, while Canadian and European guidelines (2011) are target-based.
  • Significant variations exist in risk assessment and treatment targets between guidelines.
  • These differences lead to considerable practice variations and potentially increased healthcare costs in some countries.

Conclusions:

  • Discrepancies in international lipid guidelines complicate standardized patient care.
  • Variations in risk prediction tools hinder cross-country comparisons and optimal treatment selection.
  • Standardization using trial data and validated risk scores is needed to improve ASCVD outcomes.